Chapter 1: The human hypothalamus in metabolic and episodic disorders

Progress in Brain Research

Volumn 153, Issue , 2006, Pages 3-45

  Swaab, D F ^a  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; OREXIN; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOPRESSIN;

ANOREXIA NERVOSA; AUTOPSY; BINGE EATING DISORDER; BIRTH; BRAIN; BRAIN DEVELOPMENT; BULIMIA; CIRCADIAN RHYTHM; EATING DISORDER; HUMAN; HYPERPHAGIA; HYPOTHALAMUS; HYPOTHALAMUS DISEASE; HYPOTHALAMUS TUMOR; HYPOTHALAMUS VENTROMEDIAL NUCLEUS; MAJOR DEPRESSION; METABOLIC DISORDER; METABOLIC REGULATION; MOLECULAR GENETICS; NARCOLEPSY; NEUROCYSTICERCOSIS; NIGHT EATING SYNDROME; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PHOTOTHERAPY; PRADER WILLI SYNDROME; PRIORITY JOURNAL; REVIEW; SEASONAL AFFECTIVE DISORDER; SEASONAL VARIATION; VENTROMEDIAL HYPOTHALAMUS SYNDROME; CONGENITAL MALFORMATION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

EATING DISORDERS; HUMANS; HYPOTHALAMUS; METABOLIC DISEASES; SEASONAL AFFECTIVE DISORDER;

EID: 33746287564     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(06)53001-8     Document Type: Review

References (246)

1. Alkemade A., Unmehopa U.A., Wiersinga W.M., Swaab D.F., and Fliers E. Glucocorticoids decrease TRH mRNA expression in the paraventricular nucleus (PVN) of the human hypothalamus. J. Clin. Endocrinol. Metab. 90 (2005) 323-327
2. Arletti R., Benelli A., and Bertolini A. Influence of oxytocin on feeding behavior in the rat. Peptides 10 (1989) 89-93
3. Balligand J.L., Brichard S.M., Brichard V., Desager J.P., and Lambert M. Hypoleptinemia in patients with anorexia nervosa: loss of circadian rhythm and unresponsiveness to short-term refeeding. Eur. J. Endocrinol. 138 (1998) 415-420
4. Bastrup-Madsen P., and Greisen O. Hypothalamic obesity in acute leukaemia. Acta Haematol. 29 (1963) 109-116
5. Bellipanni G., Bianchi P., Pierpaoli W., Bulian D., and Ilyia E. Effects of melatonin in perimenopausal and menopausal women: a randomized and placebo controlled study. Exp. Gerontol. 36 (2001) 297-310
6. Benelli A., Bertolini A., and Arletti R. Oxytocin-induced inhibition of feeding and drinking: no sexual dimorphism in rats. Neuropeptides 20 (1991) 57-62
7. Bierwolf C., Kern W., Mölle M., Born J., and Fehm H.L. Rhythms of pituitary-adrenal activity during sleep in patients with Cushing's disease. Exp. Clin. Endocrinol. Diabetes 108 (2000) 470-479
8. Biller B.M.K. Pathogenesis of pituitary Cushing's syndrome. Endocrinol. Metab. Clin. N. Am. 23 (1994) 547-554
9. Birketvedt G.S., Florholmen J., Sundsfjord J., Østerud B., Dinges D., Bilker W., and Stunkard A. Behavioral and neuroendocrine characteristics of the night-eating syndrome. JAMA 282 (1999) 657-663
10. Birketvedt G.S., Sundsfjord J., and Florholmen J.R. Hypothalamic-pituitary adrenal axis in the night eating syndrome. Am. J. Physiol. 282 (2002) E366-E369
11. Björntorp P., and Rosmond R. Hypothalamic origin of the metabolic syndrome X. Ann. N.Y. Acad. Sci. 892 (1999) 297-307
12. Blouin A., Blouin J., Aubin P., Carter J., Goldstein C., Boyer H., and Perez E. Seasonal patterns of bulimia nervosa. Am. J. Psychiatry 149 (1992) 73-81
13. Blouin A.G., Blouin J.H., Iversen H., Carter J., Goldstein C., Goldfield G., and Perez E. Light therapy in bulimia nervosa: a double-blind, placebo-controlled study. Psychiatry Res. 60 (1996) 1-9
14. Bonnet F., Irving K., Terra J.-L., Nony P., Berthezène F., and Moulin P. Depressive symptoms are associated with unhealthy lifestyles in hypertensive patients with the metabolic syndrome. J. Hypertension 23 (2005) 611-617
15. Branson R., Potoczna N., Kral J.G., Lentes K.-U., Hoehe M.R., and Horber F.F. Binge eating as a major phenotype of melanocortin 4 receptor gene mutations. N. Engl. J. Med. 348 (2003) 1096-1103
16. Braun D.L., Sunday S.R., Fornari V.M., and Halmi K.A. Bright light therapy decreases winter binge frequency in women with bulimia nervosa: a double-blind, placebo-controlled study. Comprehensive Psychiatry 40 (1999) 442-448
17. Bresson J.L., Clavequin M.C., Fellmann D., and Bugnon C. Human corticoliberin hypothalamic neuroglandular system: comparative immunocytochemical study with anti-rat and anti-ovine corticotropin-releasing factor sera in the early stages of development. Brain Res. Dev. Brain Res. 32 (1987) 241-246
18. Brown G.M. Day-Night rhythm disturbance, pineal function and human disease. Horm. Res. 37 Suppl. 3 (1992) 105-111
19. Brown S.E., Varghese F.P., and McEwen B.S. Association of depression with medical illness: does cortisol play a role?. Biol. Psychiatry 55 (2004) 1-9
20. Carlson M.G., Snead W.L., Oeser A.M., and Butler M.G. Plasma leptin concentrations in lean and obese human subjects and Prader-Willi syndrome: comparison of RIA and ELISA methods. J. Lab. Clin. Med. 133 (1999) 75-80
21. Carlsson A., Svennerholm L., and Winblad B. Seasonal and circadian monoamine variations in human brains examined post mortem. Acta Psychiatr. Scand. 61 Suppl 280 (1980) 75-85
22. Checkley S. The neuroendocrinology of depression and chronic stress. Br. Med. Bull. 52 (1996) 597-617
23. Chemelli R.M., Willie J.T., Sinton C.M., Elmquist J.K., Scammell T., Lee C., Richardson J.A., Williams S.C., Xiong Y., Kisanuki Y., Fitch T.E., Nakazato M., Hammer R.E., Saper C.B., and Yanagisawa M. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98 (1999) 437-451
24. Clapham J.C., Arch J.R.S., and Tadayyon M. Anti-obesity drugs: a critical review of current therapies and future opportunities. Pharmacol. Ther. 89 (2001) 81-121
25. Clément K., Vaisse C., Lahlou N., Cabrol S., Pelloux V., Cassuto D., Gourmelen M., Dina C., Chambaz J., Lacorte J.-M., Basdevant A., Bougnères P., Lebouc Y., Froguel P., and Guy-Grand B. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392 (1998) 398-401
26. Climo L.H. Anorexia nervosa associated with hypothalamic tumor: the search for clinical-pathological correlations. Psychiatr. J. Univ. Ottawa 7 (1982) 20-25
27. Cnattingius S., Hultman C.M., Dahl M., and Sparén P. Very preterm birth, birth trauma, and the risk of anorexia nervosa among girls. Arch. Gen. Psychiatry 56 (1999) 634-638
28. Coffey R.J. Hypothalamic and basal forebrain germinoma presenting with amnesia and hyperphagia. Surg. Neurol. 31 (1989) 228-233
29. Cone R.D. The central melanocortin system and energy homeostasis. Trends Endocrinol. Metab. 10 (1999) 211-216
30. Conroy J.M., Grebe T.A., Becker L.A., Tsuchiya K., Nicholls R.D., Buiting K., Horsthemke B., Cassidy S.B., and Schwartz S. Balanced translocation 46,XY,t(2;15) (q372;q112) associated with atypical Prader-Willi syndrome. Am. J. Hum. Genet. 61 (1997) 388-394
31. Cotrufo P., Monteleone P., d'Istria M., Fuschino A., Serino I., and Maj M. Aggressive behavioral characteristics and endogenous hormones in women with bulimia nervosa. Neuropsychobiology 42 (2000) 58-61
32. Dahmen N., Bierbrauer J., and Kasten M. Increased prevalence of obesity in narcoleptic patients and relatives. Eur. Arch. Psychiatry Clin. Neurosci. 251 (2001) 85-89
33. Dai J.P., Swaab D.F., and Buijs R.M. Distribution of vasopressin and vasoactive intestinal polypeptide (VIP) fibers in the human hypthalamus with special emphasis on suprachiasmatic nucleus efferent projections. J. Comp. Neurol. 383 (1997) 397-414
34. De Castro J.M. Seasonal rhythms of human nutrient intake and meal pattern. Physiol. Behav. 50 (1991) 243-248
35. De los Santos T., Schweizer J., Rees C.A., and Francke U. Small evolutionary conserved RNA, resembling C/D box small nucleolar RNA, is trascribed for PWCR1, a novel imprinted gene in the Prader-Willi deletion region, which is highly expressed in brain. Am. J. Hum. Genet. 67 (2000) 1067-1082
36. DeVile C.J., Sufraz R., Lask B.D., and Stanhope R. Occult intracranial tumours masquerading as early onset anorexia nervosa. Br. Med. J. 311 (1995) 1359-1360
37. De Vries M.W., and Peeters F.P.M.L. Melatonin as a therapeutic agent in the treatment of sleep disturbance in depression. J. Nerv. Ment. Dis. 185 (1997) 201-202
38. Dinan T.G., Lavelle E., Scott L.V., Newell-Price J., Medbak S., and Grossman A.B. Desmopressin normalizes the blunted adrenocorticotropin response to corticotropin-releasing hormone in melancholic depression: evidence of enhanced vasopressinergic responsivity. J. Clin. Endocrinol. Metab. 84 (1999) 2238-2240
39. Dingemans A.E., Bruna M.J., and Van Furth E.F. Binge eating disorder: a review. Int. J. Obesity 26 (2002) 299-307
40. Dorn L.D., Burgess E.S., Dubbert B., Simpson S.-E., Friedman T., Kling M., Gold P.W., and Chrousos G.P. Psychopathology in patients with endogenous Cushing's syndrome: 'atypical' or melancholic features. Clin. Endocrinol. 43 (1995) 433-442
41. Dorn L.D., Burgess E.S., Friedman T.C., Dubbert B., Gold P.W., and Chrousos G.P. The longitudinal course of psychopathology in Cushing's syndrome after correction of hypercortisolism. J. Clin. Endocrinol. Metab. 82 (1997) 912-919
42. Douglas J.E., and Bryon M. Interview data on severe behavioural eating difficulties in young children. Arch. Diseases Childhood 75 (1996) 304-308
43. Eastman C.I., Young M.A., Fogg L.F., Liu L., and Meaden P.M. Bright light treatment of winter depression. A placebo-controlled trial. Arch. Gen. Psychiatry 55 (1998) 883-889
44. Engelmann M., Landgraf R., and Wotjak C.T. The hypothalamic-neurohypophysial system regulates the hypothalamic-pituitary-adrenal axis under stress: an old concept revisited. Frontiers Neuroendocrinol. 25 (2004) 132-149
45. Erkut Z.A., Pool C.W., and Swaab D.F. Glucocorticoids suppress corticotropin-releasing hormone and vasopressin expression in human hypothalamic neurons. J. Clin. Endocrinol. Metab. 83 (1998) 2066-2073
46. Farooqi I.S., Jebb S.A., Langmack G., Lawrence E., Cheetham C.H., Prentice A.M., Hughes I.A., McCamish M.A., and O'Rahilly S. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. New Engl. J. Med. 341 (1999) 879-884
47. Farooqi I.S., Keogh J.M., Yeo G.S.H., Lank E.J., Cheetham T., and O'Rahilly S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N. Engl. J. Med. 348 (2003) 1085-1095
48. Ferrari E., Fraschini F., and Brambilla F. Hormonal circad-ian rhythms in eating disorders. Biol. Psychiatry 27 (1990) 1007-1020
49. Flynn F.G., Cummings J.L., and Tomiyasu U. Altered behavior associated with damage to the ventromedial hypothalamus: a distinctive syndrome. Behav. Neurol. 1 (1988) 49-58
50. Fornari V.M., Braun D.L., Sunday S.R., Sandberg D.E., Matthews M., Chen L.-L., Mandel F.S., Halmi K.A., and Katz J.L. Seasonal patterns in eating disorder subgroups. Compr. Psychiatry 35 (1994) 450-456
51. Friedman S., Even C., Dardennes R., and Guelfi J.D. Light therapy, obesity, and night-eating syndrome. Am. J. Psychiatry 159 (2002) 875-876
52. Fronczek R., Lammers G.J., Balesar R., Unmehopa U.A., and Swaab D.F. The number of hypothalamic hypocretin (orexin) neurons is not affected in Prader-Willi Syndrome. J. Clin. Endocrinol. Metab. 90 (2005) 5466-5470
53. Galderisi S., Mucci A., Monteleone P., Sorrentino D., Piegari G., and Maj M. Neurocognitive functioning in subjects with eating disorders: the influence of neuroactive steroids. Biol. Psychiatry 53 (2003) 921-927
54. Gautier J.-F., Del Parigi A., Chen K., Salbe A.D., Bandy D., Pratley R.E., Ravussin E., Reiman E.M., and Tataranni P.A. Effect of satiation on brain activity in obese and lean women. Obesity Res. 9 (2001) 676-684
55. Geddes J.R., and Lawrie S.M. Obstetric complications and schizophrenia: a meta analysis. Br. J. Psychiatry 167 (1995) 786-793
56. Gencik M., Dahmen N., Wieczorek S., Kasten M., Bierbrauer J., Anghelescu I., Szegedi A., Saecker M., and Epplen J.T. A prepro-orexin gene polymorphism is associated with narcolepsy. Neurology 56 (2001) 115-117
57. Ghandirian A.-M., Marini N., Jabalpurwala S., and Steiger H. Seasonal mood patterns in eating disorders. Gen. Hosp. Psychiatry 21 (1999) 354-359
58. Gold P.W., Licinio J., Wong M.L., and Chrousos G.P. Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs. Ann. N.Y. Acad. Sci. 771 (1995) 716-729
59. Gold R.M. Hypothalamic obesity: the myth of the ventromedial nucleus. Science 182 (1973) 488-490
60. Goldstone A.P., Unmehopa U.A., Bloom S.R., and Swaab D.F. Hypothalamic neuropeptide Y and agouti-related protein are increased in human illness but not in Prader-Willi syndrome and other obese subjects. J. Clin. Endocrinol. Metab. 87 (2002) 927-937
61. Goldstone A.P., Unmehopa U., and Swaab D.F. Hypothalamic growth hormone-releasing hormone (GHRH). cell number in human illness, Prader-Willi syndrome and obesity. Clin. Endocrinol. 58 (2003) 743-755
62. Gomez F., Chapleur M., Fernette B., Burlet C., Nicolas J.-P., and Burlet A. Arginine vasopressin (AVP) depletion in neurons of the suprachiasmatic nuclei affects the AVP content of the paraventricular neurons and stimulates adrenocorticotrophic hormone release. J. Neurosci. Res. 50 (1997) 565-574
63. Gorwood P., Kipman A., and Foulon C. The human genetics of anorexia nervosa. Eur. J. Pharmacol. 480 (2003) 163-170
64. Grilo C.M., and Masheb R.M. Childhood maltreatment and personality disorders in adult patients with binge eating disorder. Acta Psychiatr. Scand. 106 (2002) 183-188
65. Hall J.E., Hildebrandt D.A., and Kuo J. Obesity hypertension: role of leptin and sympathetic nervous system. Am. J. Hypertension 14 Suppl. 1 (2001) 103S-115S
66. Halmi K.A., Goldberg S.C., Casper R.C., Eckert E.D., and Davis J.M. Pretreatment predictors of outcome in anorexia nervosa. Br. J. Psychiat. 134 (1979) 71-78
67. Harmatz M.G., Well A.D., Overtree C.E., Kawamura K.Y., Rosal M., and Ockene I.S. Seasonal variation of depression and other moods: a longitudinal approach. J. Biol. Rhythms 15 (2000) 344-350
68. Haugh R.M., and Markesbery W.R. Hypothalamic astrocytoma. Syndrome of hyperphagia, obesity, and disturbances of behavior and endocrine and autonomic function. Arch. Neurol. 40 (1983) 560-563
69. Hebebrand J., Fichter M., Gerber G., Görg T., Hermann H., Geller F., Schäfer H., Remschmidt H., and Hinney A. Genetic predisposition to obesity in bulimia nervosa: a mutation screen of the melanocortin-4 receptor gene. Mol. Psychiatry 7 (2002) 647-651
70. Hebebrand J., Geller F., Dempfle A., Heinzel-Gutenbrunner M., Raab M., Gerber G., Wermter A.-K., Horro F.F., Blundell J., Schäfer H., Remschmidt H., Herpertz S., and Hinney A. Binge-eating episodes are not characteristic of carriers of melanocortin-4 receptor gene mutations. Mol. Psychiatry 9 (2004) 796-800
71. Heim C., and Nemeroff C.B. The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biol. Psychiatry 49 (2001) 1023-1039
72. Heinbecker P. The pathogenesis of Cushing's syndrome. Medicine 23 (1944) 225-247
73. Helbing-Zwanenburg B., Kamphuisen H.A., and Mourtazaev M.S. The origin of excessive daytime sleepiness in the Prader-Willi syndrome. J. Intellect. Disabil. Res. 37 (1993) 533-541
74. Hinney A., Hoch A., Geller F., Schäfer H., Siegfried W., Goldschmidt H., Remschmidt H., and Hebebrand J. Ghrelin gene: identification of missense variants and a frameshift mutation in extremely obese children and adolescents and healthy normal weight students. J. Clin. Endocrinol. Metab. 87 (2002) 2716-2719
75. Hofman M.A. Seasonal rhythms of neuronal activity in the human biological clock: a mathematical model. Biol. Rhythm Res. 32 (2001) 17-34
76. Hofman M.A. Circadian oscillations of neuropeptide expression in the human biological clock. J. Comp. Physiol. A 189 (2003) 823-832
77. Hofman M.A., Purba J.S., and Swaab D.F. Annual variations in the vasopressin neuron population of the human suprachiasmatic nucleus. Neuroscience 53 (1993) 1103-1112
78. Hofman M.A., and Swaab D.F. The human hypothalamus: comparative morphometry and photoperiodic influences. In: Swaab D.F., Hofman M.A., Mirmiran M., Ravid R., and Van Leeuwen F.W. (Eds). The Human Hypothalamus in Health and Disease. Progress in Brain Research Vol. 93 (1992), Elsevier, Amsterdam 133-149
79. Hofman M.A., and Swaab D.F. Seasonal changes in the suprachiasmatic nucleus of man. Neurosci. Lett. 139 (1992) 257-260
80. Hofman M.A., and Swaab D.F. Diurnal and seasonal rhythms of neuronal activity in the suprachiasmatic nucleus of humans. J. Biol. Rhythms 8 (1993) 283-295
81. Honnebier W.J., and Swaab D.F. The influence of anencephaly upon intrauterine growth of fetus and placenta and upon gestation length. J. Obstet. Gynaecol. Br. Cmwlth. 80 (1973) 577-588
82. Hsu L.K.G., Mulliken B., McDonagh B., Krupa Das S., Rand W., Fairburn C.G., Rolls B., McCrory M.A., Saltzman E., Shikora S., Dwyer J., and Roberts S. Binge eating disorder in extreme obesity. Int. J. Obesity 26 (2002) 1398-1403
83. Inder W.J., Donald R.A., Prickett T.C.R., Frampton C.M., Sullivan P.F., Mulder R.T., and Joyce P.R. Arginine vasopressin is associated with hypercortisolemia and suicide attempts in depression. Biol. Psychiatry 42 (1997) 744-747
84. Iwamoto H.S., Rudolph A.M., Keil L.C., and Heymann M.A. Hemodynamic responses of the sheep fetus to vasopressin infusion. Circ. Res. 44 (1979) 430-436
85. Jackson R.S., Creemers J.W.M., Ohagi S., Raffin-Sanson M.-L., Sanders L., Mantague C., Hutton J.C., and O'Rahilly S. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 ((PC1) gene. Nat. Genet. 16 (1997) 303-306
86. Jay P., Rougeulle C., Massacrier A., Moncla A., Mattei M.-G., Malzac P., Roëckel N., Taviaux S., Bergé Lefranc J.-L., Cau P., Berta P., Lalande M., and Muscatelli F. The human necdin gene, NDN, is maternally imprinted and located in the Prader-Willi syndrome chromosomal region. Nat. Genet. 17 (1997) 357-361
87. Jean-Louis G., Von Gizycki H., and Zizi F. Melatonin effects on sleep, mood, and cognition in elderly with mild cognitive impairment. J. Pineal Res. 25 (1998) 177-183
88. Johansson C., Willeit M., Smedh C., Ekholm J., Paunio T., Kieseppä T., Lichtermann D., Praschak-Rieder N., Neumeister A., Nilsson L.-G., Kasper S., Peltonen L., Adolfsson R., Schalling M., and Partonen T. Circadian clock-related polymorph-isms in seasonal affective disorder and their relevance to diurnal preference. Neuropsychopharmacology 28 (2003) 734-739
89. Jong M.T.C., Gray T.A., Ji Y., Glenn C.C., Saitoh S., Driscoll D.J., and Nicholls R.D. A novel imprinted gene, encoding a RING zinc-finger protein, and overlapping antisense transcript in the Prader-Willi syndrome critical region. Hum. Mol. Genet. 8 (1999) 783-793
90. Joo E.Y., Tae W.S., Kim J.H., Kim B.T., and Hong S.B. Glucose hypometabolism of hypothalamus and thalamus in narcolepsy. Ann. Neurol. 56 (2004) 437-440
91. Kadotani H., Faraco J., and Mignot E. Genetic studies in the sleep disorder narcolepsy. Genome Res. 8 (1998) 427-434
92. Kalsbeek A., Buijs R.M., Van Heerikhuize J.J., Arts M., and Van der Woude T.P. Vasopressin-containing neurons of the suprachiasmatic nuclei inhibit corticosterone release. Brain Res. 580 (1992) 62-67
93. Kaplan J., Fredrickson P.A., and Richardson J.W. Sleep and breathing in patients with the Prader-Willi syndrome. Mayo Clin. Proc. 66 (1991) 1124-1126
94. Katz G., Durst R., Zislin Y., Barel Y., and Knobler H.Y. Psychiatric aspects of jet lag: review and hypothesis. Med. Hypotheses 56 (2001) 20-23
95. Kaye W.H. Neuropeptide abnormalities in anorexia nervosa. Psychiatry Res. 62 (1996) 65-74
96. Kaye W.H., Frank G.K., Bailer U.F., Henry S.E., Meltzer C.C., Price J.C., Mathis C.A., and Wagner A. Serotonin alterations in anorexia and bulimia nervosa: new insights from imaging studies. Physiol. Behav. 85 (2005) 73-81
97. Kaye W., Gendall K., and Strober M. Serotonin neuronal function and selective serotonin reuptake inhibitor treatment in anorexia and bulimia nervosa. Biol. Psychiatry 44 (1998) 825-838
98. Kelly, J.J., Mangos, G., Williamson, P.M. and Whitworth, J. A. (1998) Cortisol and hypertension. Clin. Exp. Pharmacol. Physiol. (suppl. 25): S1-S6.
99. Keverne E.B., Fundele R., Narasimha M., Barton S.C., and Surani M.A. Genomic imprinting and the differential roles of parental genomes in brain development. Brain Res. Dev. 92 (1996) 91-100
100. Kobayashi H., Ogawa Y., Shintani M., Ebihara K., Shimodahira M., Iwakura T., Hino M., Ishihara T., Ikekubo K., Kurahachi H., and Nakao K. A novel homozygous missense mutation of melanocortin-4 receptor (MC4R) in a Japanese woman with severe obesity. Diabetes 51 (2002) 243-246
101. Kok S.W., Meinders A.E., Overeem S., Lammers G.J., Roelfsema F., Frolich M., and Pijl H. Reduction of plasma leptin levels and loss of its circadian rhythmicity in hypocretin (orexin)-deficient narcoleptic humans. J. Clin. Endocrinol. Metab. 87 (2002) 805-809
102. Koutcherov Y., Mai J.K., Ashwell K.W.S., and Paxinos G. Organization of human hypothalamus in fetal development. J. Comp. Neurol. 446 (2002) 301-324
103. Kräuchi K., and Wirz-Justice A. The four seasons: food intake frequency in seasonal affective disorder in the course of a year. Psychiatry Res. 25 (1988) 323-338
104. Kräuchi K., Wirz-Justice A., and Graw P. High intake of sweets late in the day predicts a rapid and persistant response to light therapy in winter depression. Psychiatry Res. 46 (1993) 107-117
105. Kripke D.F. Light treatment for nonseasonal depression: speed, efficacy, and combined treatment. J. Affect. Disord. 49 (1998) 109-117
106. Krude H., Biebermann H., Luck W., Horn R., Brabant G., and Grüters A. Severe early onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat. Genet. 19 (1998) 155-157
107. Krude H., and Grüters A. Implications of proopiomelanocortin (POMC) mutations in humans: the POMC deficiency syndrome. Trends Endocrinol. Metabol. 11 (2000) 15-22
108. Kruk M.R., Westphal K.G.C., Van Erp A.M.M., Van Asperen J., Cave B.K., Slater E., De Koning J., and Haller J. The hypothalamus: cross-roads of endocrine and behavioural regulation in grooming and aggression. Neurosci. Biobehav. Rev. 23 (1998) 163-177
109. Kuslich C.D., Kobori J.A., Mohapatra G., Gregorio-King C., and Donlon T.A. Prader-Willi syndrome is caused by disruption of the SNRPN gene. Am. J. Genet. 64 (1999) 70-76
110. Kusumi I., Ohmori T., Kohsaka M., Ito M., Honma H., and Koyama T. Chronobiological approach for treatment-resistant rapid cycling affective disorders. Soc. Biol. Psychol. 37 (1995) 553-559
111. Lam R.W., Goldner E.M., and Grewal A. Seasonality of symptoms in anorexia and bulimia nervosa. Int. J. Eat. Disord. 19 (1996) 35-44
112. Lam R.W., Goldner E.M., Solyom L., and Remick R.A. A controlled study of light therapy for bulimia nervosa. Am. J. Psychiatry 151 (1994) 744-750
113. Lam R.W., Lee S.K., Tam E.M., Grewal A., and Yatham L.N. An open trial of light therapy for women with seasonal affective disorder and comorbid bulimia nervosa. J. Clin. Psychiatry 62 (2001) 164-168
114. Lam R.W., Zis A.P., Grewal A., Delgado P.L., Charney D.S., and Krystal J.H. Effects of rapid tryptophan depletion in patients with seasonal affective disorder in remission after light therapy. Arch. Gen. Psychiatry 53 (1996) 41-44
115. Lambert G., Reid C., Kaye D., Jennings G., and Esler M. Effect of sunlight and season on serotonin turnover in the brain. Lancet 360 (2002) 1840-1842
116. Lee Y.-S., Kok-Seng Poh L., and Loke K.-Y. A novel melanocortin 3 receptor gene (MC3R) mutation associated with severe obesity. J. Clin. Endocrinol. Metab. 87 (2002) 1423-1426
117. Leibowitz S.F., Hammer N.J., and Chang K. Hypothalamic paraventricular nucleus lesions produce overeating and obesity in the rat. Physiol. Behav. 27 (1981) 1031-1040
118. Leppämäki S., Partonen T., and Lönnqvist J. Bright-light exposure combined with physical exercise elevates mood. J. Affect. Disord. 72 (2002) 139-144
119. Lester N.A., Keel P.K., and Lipson S.F. Symptom fluctuation in bulimia nervosa: relation to menstrual-cycle phase and cortisol levels. Psychol. Med. 33 (2003) 51-60
120. Levitan R.D., Kaplan A.S., Levitt A.J., and Joffe R.T. Seasonal fluctuations in mood and eating behavior in bulimia nervosa. Int. J. Eating Disorders 16 (1994) 295-299
121. Levitan R.D., Kaplan A.S., and Rockert W. Characterization of the 'seasonal' bulimic patient. Int. J. Eating Disorders 19 (1996) 187-192
122. Levitan R.D., Masellis M., Basile V.S., Lam R.W., Kaplan A.S., Davis C., Muglia P., Mackenzie B., Tharmalingam S., Kennedy S.H., Macciardi F., and Kennedy J.L. The dopamine-4 receptor gene associated with binge eating and weight gain in women with seasonal affective disorder: an evolutionary perspective. Biol. Psychiatry 56 (2004) 665-669
123. Lewy A.J., Bauer V.K., Cutler N.L., and Sack R.L. Melatonin treatment of winter depression: a pilot study. Psychiatry Res. 77 (1998) 57-61
124. Lewy A.J., and Sack R.L. The role of melatonin and light in the human circadian system. Prog. Brain Res. 111 (1996) 205-216
125. Licinio J., Wong M.-L., and Gold P.W. The hypothalamic-pituitary-adrenal axis in anorexia nervosa. Psychiatry Res. 62 (1996) 75-83
126. Lin L., Faraco J., Li R., Kadotani H., Rogers W., Lin X., Qiu X., De Jong P.J., Nishino S., and Mignot E. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98 (1999) 365-376
127. Lindgren A.C., Hagenäs L., Müller J., Blichfeldt S., Rosenborg M., Brismar T., and Ritzén E.M. Effects of growth hormone treatment on growth and body composition in Prader-Willi syndrome: a preliminary report. Acta Paediatr. (Suppl) 423 (1997) 60-62
128. Lino R.S., Reis L.C., Reis M.A., Gobbi H., and Teixeira V.P.A. Hypothalamic neurocysticerosis as a possible cause of obesity. Trans. R. Soc. Trop. Med. Hyg. 94 (2000) 294
129. Liu Y., Gao J.-H., Liu H.-L., and Fox P.T. The temporal response of the brain after eating revealed by functional MRI. Nature 405 (2000) 1058-1062
130. Lustig R.H., Rose S.R., Burghen G.A., Velasquez-Mieyer P., Broome D.C., Smith K., Li H., Hudson M.M., Heideman R.L., and Kun L.E. Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by a somatostatin agonist. J. Pediatr. 135 (1999) 162-168
131. MacNeil D.J., Howard A.D., Guan X., Fong T.M., Nargund R.P., Bednarek M.A., Goulet M.T., Weinberg D.H., Strack A.M., Marsh D.J., Chen H.Y., Shen C.P., Chen A.S., Rosenblum C.I., MacNeil T., Tota M., MacIntyre E.D., and Van der Ploeg L.H. The role of melanocortins in body weight regulation: opportunities for the treatment of obesity. Eur. J. Pharmacol. 440 (2002) 141-157
132. Maes M., Meltzer H.Y., Cosyns P., Suy E., and Schotte C. An evaluation of basal hypothalamic-pituitary-thyroid axis function in depression: results of a large-scaled and controlled study. Psychoneuroendocrinology 18 (1993) 607-620
133. Maghnie M., Triulzi F., Larizza D., Preti P., Priora C., Scotti G., and Severi F. Hypothalamic-pituitary dysfunction in growth hormone-deficient patients with pituitary abnormalities. J. Clin. Endocrinol. Metab. 73 (1991) 79-83
134. Magiakou M.A., Mastorakos G., and Chrousos G.P. Cushing syndrome. Differential diagnosis and treatment. In: Wierman M.E. (Ed). Diseases of the Pituitary: Diagnosis and Treatment. Contemporary Endocrinology Vol. 3 (1997), Humana Press Inc, Totowa, NJ 179-202
135. Martin A., State M., Koenig K., Schultz R., Dykens E.M., Cassidy S.B., and Leckman J.F. Prader-Willi syndrome. Am. J. Psychiatry 155 (1998) 1265-1273
136. Mastorakos G., and Ilias I. Maternal and fetal hypothalamic-pituitary-adrenal axes during pregnancy and postpartum. Ann. N.Y. Acad. Sci. 997 (2003) 136-149
137. Mastorakos G., and Zapanti E. The hypothalamic-pituitary-adrenal axis in the neuroendocrine regulation of food intake and obesity: the role of corticotropin releasing hormone. Nutr. Neurosci. 7 (2004) 271-280
138. Matsushita S., Suzuki K., Murayama M., Nishiguchi N., Hishimoto A., Takeda A., Shirakawa O., and Higuchi S. Serotonin transporter regulatory region polymorphism is associated with anorexia nervosa. Am. J. Med. Genet. Part B 128B (2004) 114-117
139. McElroy S.L., Kotwal R., Malhotra S., Nelson E.B., Keck P.E., and Nemeroff C.B. Are mood disorders and obesity related? A review for the mental health professional. J. Clin. Psychiatry 65 (2004) 634-651
140. McEntagart M.E., Webb T., Hardy C., and King M.D. Familial Prader-Willi syndrome: case report and a literature review. Clin. Genet. 58 (2000) 216-223
141. McMillen I.C., Phillips I.D., Ross J.T., Robinson J.S., and Owens J.A. Chronic stress-the key to parturition?. Reprod. Fertil. Dev. 7 (1995) 499-507
142. McMillen I.C., Schwartz J., Coulter C.L., and Edwards L.J. Early embryonic environment, the fetal pituitary-adrenal axis and the timing of parturition. Endocrinol. Res. 30 (2004) 845-850
143. Mergen M., Mergen H., Ozata M., Oner R., and Oner C. A novel melanocortin 4 receptor (MC4R) gene mutation associated with morbid obesity. J. Clin. Endocrinol. Metab. 86 (2001) 3448-3451
144. Meynen, G., Unmehopa, U.A., van Heerikhuize, J., Hofman, M.A., Swaab, D.F. and Hoogendijk, W.J.G. (2006) Increased arginine vasopressin mRNA expression in the human hypothalamus in depression A Preliminary Report Biol. Psychiatr., in press.
145. Mitchell A., and O'Keane V. Steroids and depression. Br. Med. J. 316 (1998) 244-245
146. Montague C.T., Farooqi I.S., Whitehead J.P., Soos M.A., Rau H., Wareham N.J., Sewter C.P., Digby J.E., Mohammed S.N., Hurst J.A., Cheetham C.H., Earley A.R., Barnett A.H., Prins J.B., and O'Rahilly S. Congenital leptin deficiency is associated with severe early onset obesity in humans. Nature 387 (1997) 903-908
147. Monteleone P., Maes M., Fabrazzo M., Tortorella A., Lin A., Bosmans E., Kenis G., and Maj M. Immunoendocrine findings in patients with eating disorders. Neuropsychobiology 40 (1999) 115-120
148. Moore R.Y., Abrahamson E.A., and Van den Pol A.N. The hypocretin neuron system: an arousal system in the human brain. Arch Ital Biol 139 (2001) 195-205
149. Müller D., Roeder F., and Orthner H. Further results of stereotaxis in the human hypothalamus in sexual deviations. First use of this operation in addiction to drugs. Neurochirurgia 16 (1973) 113-126
150. Murakami N., Furuto-Kato S., Fujisawa I., Ohyama K., Nakao S., Kuwayama A., and Kageyama N. Supra- and extrasellar pituitary microadenoma as a cause of Cushing's disease. Endocrinol. J. 45 (1998) 631-636
151. Muscatelli F., Abrous D.N., Massacrier A., Boccaccio I., Le Moal M., Cau P., and Cremer H. Disruption of the mouse necdin gene results in hypothalamic and behavioral alteration reminiscent of the human Prader-Willi syndrome. Hum. Mol. Genet. 9 (2000) 3101-3110
152. Musselman D.L., and Nemeroff C.B. Depression and endocrine disorders: focus on the thyroid and adrenal system. Br. J. Psychiatry 168 (1996) 123-128
153. Nemeroff C.B. The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions. Mol. Psychiatry 1 (1996) 336-342
154. Neudeck P., Jacoby G.E., and Florin I. Dexamethasone suppression test using saliva cortisol measurement in bulimia nervosa. Physiol. Behav. 72 (2001) 93-98
155. 123I]-2b-carbomethoxy-3b-(4-iodophenyl)tropane and single photon emission computed tomography. Biol. Psychiatry 47 (2000) 158-160
156. Neumeister A., Praschak-Rieder N., Besselmann B., Rao M.-L., Glück J., and Kasper S. Effects of tryptophan depletion on drug-free patients with seasonal affective disorder during a stable response to bright light therapy. Arch. Gen. Psychiatry 54 (1997) 133-138
157. Nevsimalova S., Vankova J., Stepanova I., Seemanova E., Mignot E., and Nishino S. Hypocretin deficiency in Prader-Willi syndrome. J. Sleep Res. 13 suppl. 1 (2004) 526
158. Newell-Price J., Jørgensen J.O.L., and Grossman A. The diagnosis and differential diagnosis of Cushing's syndrome. Horm. Res. 51 Suppl 3 (1999) 81-94
159. Nilsson M., Naessén S., Dahlman I., Lindén Hirschberg A., Gustafsson J.-A., and Dahlman-Wright K. Association of estrogen receptor β gene polymorphisms with bulimic disease in women. Mol. Psychiatry 9 (2004) 28-34
160. Nishino S., Ripley B., Overeem S., Nevsimalova S., Lammers G.J., Vankova J., Okun M., Rogers W., Brooks S., and Mignot E. Low cerebrospinal fluid hypocretin (orexin) and altered energy homeostasis in human narcolepsy. Ann. Neurol. 50 (2001) 381-388
161. O'Keane V., Dinan T.G., Scott L., and Corcoran C. Changes in hypothalamic-pituitary-adrenal axis measures after vagus nerve stimulation therapy in chronic depression. Biol. Psychiatry 58 (2005) 963-968
162. Ólafsdóttir B.R., Rye D.B., Scammell T.E., Matheson J.K., Stefánsson K., and Gulcher J.R. Polymorphisms in hypocretin/orexin pathway genes and narcolepsy. Neurology 57 (2001) 1896-1899
163. Olander E., Stamberg J., Steinberg L., and Wulfsberg E.A. Third Prader-Willi syndrome phenotype due to maternal uniparental disomy 15 with mosaic trisomy 15. Am. J. Med. Genet. 93 (2000) 215-218
164. Olson B.R., Drutarosky M.D., Chow M.S., Hruby V.J., Stricker E.M., and Verbalis J.G. Oxytocin and an oxytocin agonist administered centrally decrease food intake in rats. Peptides 12 (1991) 113-118
165. Olson B.R., Drutarosky M.D., Stricker E.M., and Verbalis J.G. Brain oxytocin receptor antagonism blunts the effects of anorexigenic treatments in rats: evidence for central oxytocin inhibition of food intake. Endocrinology 129 (1991) 785-791
166. Oosterbaan H.P., and Swaab D.F. Circulating neurohypophyseal hormones in anencephalic infants. Am. J. Obstet. Gynecol. 157 (1987) 117-119
167. Overeem S., Kok S.W., Lammers G.J., Vein A.A., Frölich M., Meinders A.E., Roelfsema F., and Pijl H. Somatotropic axis in hypocretin-deficient narcoleptic humans: altered circadian distribution of GH-secretory events. Am. J. Physiol. Endocrinol. Metab. 284 (2003) E641-E647
168. Overeem S., Mignot E., Van Dijk G., and Lammers G.J. Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives. J. Clin. Neurophysiol. 18 (2001) 78-105
169. Overeem S., Van Vliet J.A., Lammers G.J., Zitman F.G., Swaab D.F., and Ferrari M.D. The hypothalamus in episodic brain disorders. Lancet Neurol. 1 (2002) 437-444
170. Ozisik G., Achermann J.C., and Jameson J.L. The role of SF1 in adrenal and reproductive function: insight from naturally occurring mutations in humans. Mol. Genet. Metab. 76 (2002) 85-91
171. Pacchierotti C., Iapichino S., Bossini L., Pieraccini F., and Castrogiovanni P. Melatonin in psychiatric disorders: a review on the melatonin involvement in psychiatry. Front. Neuroendocrinol. 22 (2001) 18-32
172. Pérusse L., Chagnon Y.C., Weisnagel S.J., Rankinen T., Snyder E., Sands J., and Bouchard C. The human obesity map: the 2000 update. Obes. Res. 9 (2001) 135-169
173. Peyron C., Faraco J., Rogers W., Ripley B., Overeem S., Charnay Y., Nevsimalova S., Aldrich M., Reynolds D., Albin R., Li R., Hungs M., Pedrazzoli M., Padigaru M., Kucherlapati M., Fan J., Maki R., Lammers G.J., Bouras C., Kucherlapati R., Nishino S., and Mignot E. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat. Med. 6 (2000) 991-997
174. Phillips D.I.W. Fetal growth and programming of the hypothalamic-pituitary-adrenal axis. Clin. Exp. Pharmacol. Physiol. 28 (2001) 967-970
175. Phillips D.I.W., Fall C.H.D., Cooper C., Norman R.J., Robinson J.S., and Owens P.C. Size at birth and plasma leptin concentrations in adult life. Int. J. Obesity 23 (1999) 1025-1029
176. Pijl H. Reduced dopaminergic tone in hypothalamic neural circuits: expression of a "thrifty" genotype underlying the metabolic syndrome?. Eur. J. Pharmacol. 480 (2003) 125-131
177. Piovesan A., Panarelli M., Terzolo M., Osella G., Matrella C., Paccotti P., and Angeli A. 24-Hour profiles of blood pressure and heart rate in Cushing's syndrome: relationship between cortisol and cardiovascular rhythmicities. Chronobiol. Int. 7 (1990) 263-265
178. Pohjavuori M., and Fyhrquist J. Hemodynamic significance of vasopressin in the newborn infant. J. Pediatr. 97 (1980) 462-465
179. Polivy J., and Herman C.P. Causes of eating disorders. Ann. Rev. Psychol. 53 (2002) 187-213
180. Posternak M.A., and Zimmerman M. Lack of association between seasonality and psychopathology in psychiatric outpatients. Psychiat. Res. 112 (2002) 187-194
181. Prasko J., Horacek J., Klaschka J., Kosova J., Ondrackova I., and Sipek J. Bright light therapy and/or imipramine for inpatients with recurrent non-seasonal depression. Neuroendocrinol. Lett. 23 (2002) 109-113
182. Purba J.S., Hoogendijk W.J.G., Hofman M.A., and Swaab D.F. Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. Arch. Gen. Psychiatry 53 (1996) 137-143
183. Raadsheer F.C., Hoogendijk W.J.G., Stam F.C., Tilders F.J.C., and Swaab D.F. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology 60 (1994) 436-444
184. Raadsheer F.C., Van Heerikhuize J.J., Lucassen P.J., Hoogendijk W.J.G., Tilders F.J.H., and Swaab D.F. Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. Am. J. Psychiatry 152 (1995) 1372-1376
185. Raff H. Salivary cortisol: a useful measurement in the diagnosis of Cushing's syndrome and the evaluation of the hypothalamic-pituitary-adrenal axis. Endocrinologist 10 (2000) 9-17
186. Ravelli G.-P., Stein Z.A., and Susser M.W. Obesity in young men after famine exposure in utero and early infancy. N. Engl. J. Med. 295 (1976) 349-353
187. Reeves A.G., and Plum F. Hyperphagia, rage, and dementia accompanying a ventromedial hypothalamic neoplasm. Arch. Neurol. 20 (1969) 616-624
188. Ren J., Lee S., Pagliardini S., Gérard M., Stewart C.L., Greer J.J., and Wevrick R. Absence of Ndn, encoding the Prader-Willi syndrome-deleted gene necdin, results in congenital deficiency of central respiratory drive in neonatal mice. J. Neurosci. 23 (2003) 1569-1573
189. Ribasés M., Gratacòs M., Armengol L., De Cid R., Badía A., Jiménez L., Solano R., Vallejo J., Fernández F., and Estivill X. Met66 in the brain-derived neurotrophic factor (BDNF) precursor is associated with anorexia nervosa restrictive type. Mol. Psychiatry 8 (2003) 745-751
190. Ribasés M., Gratacòs M., Fernández-Aranda F., Bellodi L., Boni C., Anderluh M., Cavallini M.C., Cellini E., Di Bella D., Erzegovesi S., Foulon C., Gabrovsek M., Gorwood P., Hebebrand J., Hinney A., Holliday J., Hu X., Karwautz A., Kipman A., Komel R., Nacmias B., Remschmidt H., Ricca V., Sorbi S., Wagner G., Treasure J., Collier D.A., and Estivill X. Association of BDNF with anorexia, bulimia and age of onset of weight loss in six European populations. Hum. Mol. Genet. 13 (2004) 1205-1212
191. Richdale A.L., Cotton S., and Hibbit K. Sleep and behaviour disturbance in Prader-Willi syndrome: a questionnaire study. J. Intellect. Disabil. Res. 43 (1999) 380-392
192. Roessmann U., Velasco M.E., Small E.J., and Hori A. Neuropathology of septo-optic dysplasia (De Morsier syndrome) with immunohistochemical studies of the hypothalamus and pituitary gland. J. Neuropathol. Exp. Neurol. 46 (1987) 597-608
193. Rogers R.C., and Hermann G.E. Oxytocin, oxytocin antagonist, TRH, and hypothalamic paraventricular nucleus stimulation effects on gastric motility. Peptides 8 (1986) 505-513
194. Rosenbaum M., Leibel R.L., and Hirsch J. Obesity. N. Engl. J. Med. 337 (1997) 396-407
195. Rosenthal N.E., Genhart M., Jacobsen F.M., Skwerer R.G., and Wehr T.A. Disturbance of appetite and weight regulation in seasonal affective disorder. Ann. N.Y. Acad. Sci. 499 (1987) 216-230
196. Rosmond R., Chagnon Y.C., Holm G., Chagnon M., Pérusse L., Lindell K., Carlsson B., Bouchard C., and Björntorp P. A glucocorticoid receptor gene marker is associated with abdominal obesity, leptin, and dysregulation of the hypothalamic-pituitary-adrenal axis. Obesity Res. 8 (2000) 211-218
197. Rosmond R., Ukkola O., Bouchard C., and Björntorp P. Polymorphisms in exon 3 of the proopiomelanocortin gene in relation to serum leptin, salivary cortisol, and obesity in Swedish men. Metabolism 51 (2002) 642-644
198. Salehi, M., et al., (2005) Division of Endocrinology and Metabolism, Department of Medicine, Beth Israel Medical Center and Albert Einstein College of Medicine, New York, NY 10003, USA.
199. Schalin-Jäntti C., Valli-Jaakola K., Oksanen L., Martelin E., Laitinen K., Krusius T., Mustajoki P., Heikinheimo M., and Kontula K. Melanocortin-3-receptor gene variants in morbid obesity. Int. J. Obesity 27 (2003) 70-74
200. Schuld A., Blum W.F., Uhr M., Haack M., Kraus T., Holsboer F., and Pollmächer T. Reduced leptin levels in human narcolepsy. Neuroendocrinology 72 (2000) 195-198
201. Shinoda M., Tsugu A., Oda S., Masuko A., Yamaguchi T., Yamaguchi T., Tsugane R., and Sato O. Development of akinetic mutism and hyperphagia after left thalamic and right hypothalamic lesions. Child's Nerv. Syst. 9 (1993) 243-245
202. Shuto Y., Shibasaki T., Otagiri A., Kuriyama H., Ohata H., Tamura H., Kamegai J., Sugihara H., Oikawa S., and Wakabayashi I. Hypothalamic growth hormone secretagogue receptor regulates growth hormone secretion feeding, and adiposity. J. Clin. Invest. 109 (2002) 1429-1436
203. Siegel J.M. Narcolepsy: a key role for hypocretins (orexins). Cell 98 (1999) 409-412
204. Smeets P.A.M., De Graaf C., Stafleu A., Van Osch M.J.P., and Van der Grond J. Functional MRI of human hypothalamic responses following glucose ingestion. NeuroImage 24 (2005) 363-368
205. Stamatakis E.A., and Hetherington M.M. Neuroimaging in eating disorders. Nutr. Neurosci. 6 (2003) 325-334
206. Stewart P.M., Penn R., Gibson R., Holder R., Parton A., Ratcliffe J.G., and London D.R. Hypothalamic abnormalities in patients with pituitary-dependent Cushing's syndrome. Clin. Endocrinol. 36 (1992) 453-458
207. Ströbel A., Issad T., Camoin L., Ozata M., and Strosberg A.D. A leptin missense mutation associated with hypogonadism and morbid obesity. Nat. Genet. 18 (1998) 213-215
208. Swaab D.F. Prader-Willi syndrome and the hypothalamus. Acta Paediatr. Suppl. 423 (1997) 50-54
209. Swaab D.F. The human hypothalamus. Basic and clinical aspects. Part I: Nuclei of the hypothalamus. In: Aminoff M.J., Boller F., and Swaab D.F. (Eds). Handbook of Clinical Neurology (2003), Elsevier, Amsterdam 476pp
210. Swaab D.F. The human hypothalamus. Basic and clinical aspects. Part II: Neuropathology of the hypothalamus and adjacent brain structures. In: Aminoff M.J., Boller F., and Swaab D.F. (Eds). Handbook of Clinical Neurology (2004), Elsevier, Amsterdam 596pp
211. Swaab D.F., Bao A.M., and Lucassen P.J. The stress system of the human brain in depression and neurodegeneration. Ageing Res. Rev. 4 (2005) 141-194
212. Swaab D.F., Boer K., and Honnebier W.J. The influence of the fetal hypothalamus and pituitary on the onset and course of parturition. In: Knight J., and O'Connor M. (Eds). The Fetus and Birth (1977), Ciba Foundation Symposium 47 Elsevier/North-Holland Biomedical Press, Amsterdam/New York 379-400
213. Swaab D.F., Purba J.S., and Hofman M.A. Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of five cases. J. Clin. Endocrinol. Metab. 80 (1995) 573-579
214. 123I]b-CIT and single photon emission computed tomography reveal reduced brain serotonin transporter availability in bulimia nervosa. Biol. Psychiatry 49 (2001) 326-332
215. Thannickal T.C., Moore R.Y., Nienhuis R., Ramanathan L., Gulyani S., Aldrich M., Cornford M., and Siegel J.M. Reduced number of hypocretin neurons in human narcolepsy. Neuron 27 (2000) 469-474
216. Thompson C., Syddall H., Rodin I., Osmond C., and Barker D.J.P. Birth weight and the risk of depressive disorder in late life. Br. J. Psychiatry 179 (2001) 450-455
217. Thorpy M. Current concepts in the etiology, diagnosis and treatment of narcolepsy. Sleep Med. 2 (2001) 5-17
218. Tobias E.S., Tolmie J.L., and Stephenson J.B. Cataplexy in the Prader-Willi syndrome. Arch. Dis. Child 87 2 (2002) 170
219. Tsai T.-F., Armstrong D., and Beaudet A.L. Necdin-deficient mice do not show lethality or the obesity and infertility of Prader-Willi syndrome. Nat. Gen. 22 (1999) 15-16
220. Turek F.W., Joshu C., Kohsaka A., Lin E., Ivanova G., McDearmon E., Laposky A., Losee-Olson S., Easton A., Jensen D.R., Eckel R.H., Takahashi J.S., and Bass J. Obesity and metabolic syndrome in circadian clock mutant mice. Science 308 (2005) 1043-1045
221. Ukkola O., Ravussin E., Jacobson P., Snyder E.E., Chagnon M., Sjöström L., and Bouchard C. Mutations in the preproghrelin/ghrelin gene associated with obesity in humans. J. Clin. Endocrinol. Metab. 86 (2001) 3996-3999
222. Van den Pol A.N. Narcolepsy: a neurodegenerative disease of the hypocretin system?. Neuron 27 (2000) 415-418
223. Van der Ploeg L.H.T. Obesity: an epidemic in need of therapeutics. Curr. Opin. Chem. Biol. 4 (2000) 452-460
224. Van Londen L., Goekoop J.G., Kerkhof G.A., Zwinderman K.H., Wiegant V.M., and De Wied D. Weak 24-h periodicity of body temperature and increased plasma vasopressin in melancholic depression. Eur. Neuropsychopharmacol. 11 (2001) 7-14
225. Van Londen L., Goekoop J.G., Van Kempen G.M.J., Frankhuijsen-Sierevogel A.C., Wiegant V.M., Van der Velde E.A., and De Wied D. Plasma levels of arginine vasopressin elevated in patients with major depression. Neuropsychopharmacology 17 (1997) 284-292
226. Van Londen L., Kerkhof G.A., Van denBerg F., Goekoop J.G., Zwinderman K.H., Frankhuijzen-Sierevogel A.C., Wiegant V.M., and De Wied D. Plasma arginine vasopressin and motor activity in major depression. Biol. Psychiatry 43 (1998) 196-204
227. Van Weel-Baumgarten E.M., Schers H.J., Van den Bosch W.J., Van den Hoogen H.J., and Zitman F.G. Long-term follow-up of depression among patients in the community and in family practice settings. A systematic review. J. Fam. Pract. 49 (2000) 1113-1120
228. Verbalis J.G., Blackburn R.E., Hoffman G.E., and Stricker E.M. Establishing behavioral and physiological functions of central oxytocin: insights from studies of oxytocin and ingestive behaviors. Adv. Exp. Med. Biol. 395 (1995) 209-225
229. Verdoux H., and Sutter A.-L. Perinatal risk factors for schizophrenia: diagnostic specificity and relationships with maternal psychopathology. Am. J. Med. Genet. 114 (2002) 898-905
230. Vescovi P.P., Rastelli G., Volpi R., Chiodera P., Di Gennaro C., and Coiro V. Circadian variations in plasma ACTH, cortisol and b-endorphin levels in normal-weight bulimic women. Neuropsychobiology 33 (1996) 71-75
231. Vink T., Hinney A., Van Elburg A.A., Van Goozen S.H.M., Sandkuijl L.A., Sinke R.J., Herpertz-Dahlmann B.-M., Hebebrand J., Remschmidt H., Van Engeland H., and Adan R.A.H. Association between an agouti-related protein gene polymorphism and anorexia nervosa. Mol. Psychiatry 6 (2001) 325-328
232. Visser M., and Swaab D.F. Life span changes in the presence of a-melanocyte-stimulating-hormone-containing cells in the human pituitary. J. Dev. Physiol. 1 (1979) 161-178
233. Von Bardeleben U., and Holsboer F. Corticol response to a combined dexamethasone-human corticotrophin-releasing hormone challenge in patients with depression. J. Neuroendocrinol. 1 (1989) 485-488
234. Walsh B.T., and Devlin M.J. Eating disorders: progress and problems. Science 280 (1998) 1387-1390
235. Wang L.-N., and Huang K.W. Hypothalamic encephalitis with oligodendrocytic glial nodules. Chin. Med. J. 104 (1991) 428-431
236. Warnes K.E., Morris M.J., Symonds M.E., Phillips I.D., Clarke I.J., Owens J.A., and McMillen I.C. Effects of increasing gestation, cortisol and maternal undernutrition on hypothalamic neuropeptide Y expression in the sheep fetus. J. Neuroendocrinol. 10 (1998) 51-57
237. Wauters M., Mertens I., Chagnon M., Rankinen T., Considine R.V., Chagnon Y.C., Van Gaal L.F., and Bouchard C. Polymorphisms in the leptin receptor gene, body composition and fat distribution in overweight and obese women. Int. J. Obesity 25 (2001) 714-720
238. Weltzin T.E., McConaha C., McKee M., Hsu L.K.G., Perel J., and Kaye W.H. Circadian patterns of cortisol, prolactin, and growth hormonal secretion during bingeing and vomiting in normal weight bulimic patients. Biol. Psychiatry 30 (1991) 37-48
239. Wharton R.H., and Bresman M.J. Neonatal respiratory depression and delay in diagnosis in Prader-Willi syndrome. Dev. Med. Child Neurol. 31 (1989) 231-236
240. Wicki W., Angst J., and Merikangas K.R. Epidemiology of seasonal depression. Eur. Arch. Psychiatry Clin. Neurosci. 241 (1992) 301-306
241. Wileman S.M., Eagles J.M., Andrew J.E., Howie F.L., Cameron I.M., McCormack K., and Naji S.A. Light therapy for seasonal affective disorder in primary care. Br. J. Psychiatry 178 (2001) 311-316
242. Wirz-Justice A. Biological rhythms in mood disorders. In: Bloom F.E., and Kupfer D.J. (Eds). Psychopharmacology: the Fourth Generation of Progress (1995), Raven Press, New York 999-1017
243. Wolkowitz O.M., Reus V.I., Chan T., Manfredi F., Raum W., Johnson R., and Canick J. Antiglucocorticoid treatment of depression: double-blind ketoconazole. Biol. Psychiatry 45 (1999) 1070-1074
244. Yamada N., Martin-Iverson M.T., Daimon K., Tsujimoto T., and Takahashi S. Clinical and chronobiological effects of light therapy on nonseasonal affective disorders. Biol. Psychiatry 37 (1995) 866-873
245. Yamatsuji M., Yamashita T., Arii I., Taga C., Tatara N., and Fukui K. Seasonal variations in eating disorder subtypes in Japan. Int. J. Eat. Disord. 33 (2003) 71-77
246. Zhou J.N., Riemersma R.F., Unmehopa U.A., Hoogendijk W.J., Van Heerikhuize J.J., Hofman M.A., and Swaab D.F. Alterations in arginine vasopressin neurons in the suprachiasmatic nucleus in depression. Arch. Gen. Psychiatry 58 (2001) 655-662